Watch the video to see the initiatives Neurizon is taking. This video was developed in collaboration with Neurizon ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Neurizon Therapeutics Limited (NUZ). However, you won't necessarily see their names in the ...

Neurizon Therapeutics has submitted a formal request to the US Food and Drug Administration (FDA) for clarification on two short-term, low-cost pharmacokinetic (PK) studies necessary to lift a ...

Neurizon Therapeutics plans to implement several initiatives to get the clinical hold lifted of its IND application for NUZ-001. The company has been in discussion with the US FDA since February ...

Neurizon Therapeutics has submitted a formal request to the US FDA for advice on pharmacokinetic studies needed to lift hold on its IND application for NUZ-001 Neurizon Therapeutics (ASX ...

Followed categories will be added to My News. Neurizon Therapeutics (ASX: NUZ) announced last month that the regulator had requested additional animal exposure data be provided to assess adequacy ...